359 related articles for article (PubMed ID: 32980695)
1. Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: A retrospective analysis of two independent cohorts.
Lin Y; Wang M; Jia J; Wan W; Wang T; Yang W; Li C; Chen X; Cao H; Zhang P; Tao K
EBioMedicine; 2020 Oct; 60():103016. PubMed ID: 32980695
[TBL] [Abstract][Full Text] [Related]
2. [A model to predict the recurrence of middle-high risk gastrointestinal stromal tumors based on preoperative fibrinogen and peripheral blood inflammatory indexes].
Li W; Peng QW; Lin Y; Wan WZ; Zeng XY; Sun X; Yang WC; Xiong Z; Liu WZ; Tao KX; Zhang P
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):896-903. PubMed ID: 32927515
[No Abstract] [Full Text] [Related]
3. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis.
Gold JS; Gönen M; Gutiérrez A; Broto JM; García-del-Muro X; Smyrk TC; Maki RG; Singer S; Brennan MF; Antonescu CR; Donohue JH; DeMatteo RP
Lancet Oncol; 2009 Nov; 10(11):1045-52. PubMed ID: 19793678
[TBL] [Abstract][Full Text] [Related]
4. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods.
Chen T; Xu L; Ye L; Qiu H; Hu Y; Liu H; Zhou Z; Li G; Yu J
Eur J Surg Oncol; 2019 Jun; 45(6):1109-1114. PubMed ID: 30594406
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a nomogram based on CT images and 3D texture analysis for preoperative prediction of the malignant potential in gastrointestinal stromal tumors.
Ren C; Wang S; Zhang S
Cancer Imaging; 2020 Jan; 20(1):5. PubMed ID: 31931874
[TBL] [Abstract][Full Text] [Related]
6. Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors.
Racz JM; Cleghorn MC; Jimenez MC; Atenafu EG; Jackson TD; Okrainec A; Venkat Raghavan L; Quereshy FA
Ann Surg Oncol; 2015 Jul; 22(7):2343-50. PubMed ID: 25472648
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen/Albumin Ratio Index Is an Independent Prognosis Predictor of Recurrence-Free Survival in Patients After Surgical Resection of Gastrointestinal Stromal Tumors.
Cao X; Cui J; Yu T; Li Z; Zhao G
Front Oncol; 2020; 10():1459. PubMed ID: 33014783
[No Abstract] [Full Text] [Related]
8. Immune-infiltration based signature as a novel prognostic biomarker in gastrointestinal stromal tumour.
Wei ZW; Wu J; Huang WB; Li J; Lu XF; Yuan YJ; Xiong WJ; Zhang XH; Wang W; He YL; Zhang CH
EBioMedicine; 2020 Jul; 57():102850. PubMed ID: 32574962
[TBL] [Abstract][Full Text] [Related]
9. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
Joensuu H; Vehtari A; Riihimäki J; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Cirilli C; Braconi C; Bordoni A; Magnusson MK; Linke Z; Sufliarsky J; Federico M; Jonasson JG; Dei Tos AP; Rutkowski P
Lancet Oncol; 2012 Mar; 13(3):265-74. PubMed ID: 22153892
[TBL] [Abstract][Full Text] [Related]
10. Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysis.
Tanimine N; Tanabe K; Suzuki T; Tokumoto N; Ohdan H
World J Surg Oncol; 2012 Feb; 10():43. PubMed ID: 22348408
[TBL] [Abstract][Full Text] [Related]
11. Reassessment of the recurrence risk of primary gastrointestinal stromal tumour after complete resection.
Yang W; Shou C; Chen Z; Hong Y; Yu H; Wang X; Wu Z; Zhang Q; Gao Y; Yu J
Scand J Gastroenterol; 2023 Jun; 58(6):684-692. PubMed ID: 36546536
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Nomogram for Gastrointestinal Stromal Tumors after Surgery Based on the SEER Database.
Sun Q; Chen Y; Li T; Zhu X; Zhu G; Ni B; Gao R; Li J
Biomed Res Int; 2022; 2022():5639174. PubMed ID: 36420093
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification systems for surgically treated localized primary Gastrointestinal Stromal Tumors (GIST). Review of literature and comparison of the three prognostic criteria: MSKCC Nomogramm, NIH-Fletcher and AFIP-Miettinen.
Belfiori G; Sartelli M; Cardinali L; Tranà C; Bracci R; Gesuita R; Marmorale C
Ann Ital Chir; 2015; 86(3):219-27. PubMed ID: 26098671
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib.
Lee CK; Goldstein D; Gibbs E; Joensuu H; Zalcberg J; Verweij J; Casali PG; Maki RG; Cioffi A; Mcarthur G; Lord SJ; Yip D; Kanjanapan Y; Rutkowski P
Eur J Cancer; 2015 May; 51(7):852-60. PubMed ID: 25801699
[TBL] [Abstract][Full Text] [Related]
16. Novel Prognostic Nomogram for Recurrence-Free Survival of Patients With Primary Gastrointestinal Stromal Tumors After Surgical Resection: Combination of Prognostic Nutritional Index and Basic Variables.
Li S; Chen D; Li S; Zhao Z; Yang H; Wang D; Zhang Z; Fu W
Front Oncol; 2020; 10():581855. PubMed ID: 33585198
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia as a novel prognostic factor in the patients of primary localized gastrointestinal stromal tumor.
Song H; Xiao X; Liu G; Zhou J
BMC Cancer; 2022 Feb; 22(1):179. PubMed ID: 35177018
[TBL] [Abstract][Full Text] [Related]
18. Development and external validation of a nomogram for individualized adjuvant imatinib duration for high-risk gastrointestinal stromal tumors: A multicenter retrospective cohort study.
Liu R; Wu Y; Gong J; Zhao R; Li L; Wan Q; Lian N; Shen X; Xia L; Shen Y; Xiao H; Wu X; Chen Y; Cen Y; Xu X
Cancer Med; 2022 Aug; 11(16):3093-3105. PubMed ID: 35297216
[TBL] [Abstract][Full Text] [Related]
19. Establishment and Verification of Prognostic Nomograms for Patients with Gastrointestinal Stromal Tumors: A SEER-Based Study.
Chen Z; Lin RM; Bai YK; Zhang Y
Biomed Res Int; 2019; 2019():8293261. PubMed ID: 31032364
[TBL] [Abstract][Full Text] [Related]
20. An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort study.
Bertsimas D; Margonis GA; Tang S; Koulouras A; Antonescu CR; Brennan MF; Martin-Broto J; Rutkowski P; Stasinos G; Wang J; Pikoulis E; Bylina E; Sobczuk P; Gutierrez A; Jadeja B; Tap WD; Chi P; Singer S
EClinicalMedicine; 2023 Oct; 64():102200. PubMed ID: 37731933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
